Moreover, survivin is overexpressed in malignant cells, including osteosarcoma [11], breast cancer [12], pancreatic cancer [13] and non-small cell lung cancer [14], and overexpression of survivin is associated with cancer cell survival and drug resistance [15–17]. Here, BIRC5 is linked to osteosarcoma.